2016 / 01

DOI: 10.24075/brsmu.2016-01-14

REVIEW

Comparative analysis of modern approaches to the performance assessment of scientific medical organizations in Russia and abroad

Aniskevich AS1, Halfin RA2, Tatarinova LV3
About authors

1 Ministry of Healthcare of the Russian Federation, Moscow, Russia

2 Higher School of Healthcare Management,
The First Sechenov Moscow State Medical University, Moscow, Russia

3 Russian Society of Regenerative Medicine, Medical Rehabilitation, Physiotherapists and Balneologists, Moscow, Russia

Correspondence should be addressed: Anna Aniskevich
Rakhmanovskii per., d. 3, Moscow, Russia, 127994, GSP-4; ur.xednay@hciveksina.anna

Received: 2016-02-20 Accepted: 2016-02-24 Published online: 2017-01-05
|
  1. Pronichkin SV, Tikhonov IP. Razrabotka sistemy kriteriev i metodicheskikh podkhodov k ekspertnoy otsenke effektivnosti deyatel'nosti nauchnykh organizatsii. Natsional'nye interesy: prioritety i bezopasnost'. 2013; 37: 13–8. Russian.
  2. Bobkov AV, Katalazhnova IN, Pavlov IV. Monitoring nauchnoi deyatel'nosti nauchno-obrazovatel'noi sistemy. Sovremennye problemy nauki i obrazovaniya. 2009; 6 (1): 49–50. Russian.
  3. Vyalkov AI, Glukhova EA, Martynchik SA. Model' monitoring formirovaniya innovatsionnykh kompetentsii kadrovogo sostava nauchnoi meditsinskoi organizatsii, orientirovannogo na sozdanie kriticheski vazhnykh tekhnologii. Sotsial'nye aspekty zdorov'ya naseleniya. 2015; 42 (2): 17. Russian.
  4. Vyalkov AI, Martynchik SA, Polesskiĭ VA. Metodologicheskie osnovy standartizatsii otsenochnoi deyatel'nosti meditsinskoi nauchnoi organizatsii. Zdravookhranenie Rossiiskoi Federatsii. 2010; 6: 3–7. Russian.
  5. Rasporyazhenie Pravitel'stva RF ot 28.12.2012 N 2580-r “Ob utverzhdenii Strategii razvitiya meditsinskoi nauki v Rossiyskoi Federatsii na period do 2025 goda” [Internet]. [cited 2016 Jan 14]. Available from: http:.www.consultant.ru/document/cons_doc_LAW_140249/. Russian.
  6. Sharabchiev YuT. Produktivnost' uchenykh: instrumenty otsenki. Nauka i innovatsii. 2013; 1 (119): 4–8. Russian.
  7. Vyalkov AI, Kucherenko VZ, Martynchik SA, Glukhova EA. Metodologicheskie osnovy upravleniya kachestvom deyatel'nosti meditsinskoi nauchnoi organizatsii v konkurentnoi srede. Problemy upravleniya zdravookhraneniem. 2010; 4: 14–19. Russian.
  8. Kucherenko VZ, Martynchik SA, Bashkina EM. Tsitirovanie v nauke i rol' elektronnykh resursov i otsenochnykh instrumentov. Problemy upravleniya zdravookhraneniem. 2009; 46 (3): 14–21. Russian.
  9. Bykov VL. Bibliometriya vchera, segodnya i zavtra: kolichestvennye pokazateli i nauchnaya etika. Morfologiya. 2013; 144 (4): 7–13. Russian.
  10. Mushlin AI, Ghomrawi HM. Comparative effectiveness research: a cornerstone of healthcare reform? Trans Am Clin Climatol Assoc. 2010; 121: 141–54; discussion 154–5.
  11. VanLare JM, Conway PH, Sox HC. Five next steps for a new national program for comparative-effectiveness research. N Engl J Med. 2010 Mar 18; 362 (11): 970–3.
  12. Platt R, Wilson M, Chan KA, Benner JS, Marchibroda J, McClellan M. The new Sentinel Network — improving the evidence of medical-product safety. N Engl J Med. 2009 Aug 13; 361 (7): 645–7.
  13. Higher Education Funding Council for England [Internet]. 2014 Research Excellence Framework [updated 2014 Dec 18]. Assessment criteria and level definitions [updated 2014 Dec 12; cited 2016 Jan 15]. Available from: http://www.ref.ac.uk/panels/assessmentcriteriaandleveldefinitions/.
  14. Larichev OI. Verbal'nyj analiz reshenii. Petrovskii AB, editor. Moscow: Nauka, 2006. Chapter 9.5.2. Organizacionnye kriterii. Russian.
  15. Smyth RL. A risk adapted approach to the governance of clinical trials. BMJ. 2011 Oct 25; 343: d6756.
  16. Perkhov VI, Stebunova RV, Yankevich DS, Yurkin YuYu. Analiz zarubezhnogo opyta finansirovaniya i organizatsii nauchnykh issledovanii v oblasti zdravookhraneniya. Menedzher zdravookhraneniya. 2013; 7: 49–56. Russian.
  17. Califf RM. The patient-centered outcomes research network: a national infrastructure for comparative effectiveness research. N C Med J. 2014 May–Jun; 75 (3): 204–10.
  18. Lee D, Kim S, Cha SH. Evaluating the effectiveness of research centers and institutes in universities: Disciplines and life cycle stages. KEDI J Educ Policy. 2014; 11 (1): 119.
  19. Ranking of Research Institutions SIR World Report 2010 Health Sciences [Internet]. SCImago Journal & Country Rank. [cited 2016 Jan 15]. Available from: http:www.scimagojr.com.
  20. Selby JV, Lipstein SH. PCORI at 3 years — progress, lessons, and plans. N Engl J Med. 2014 Feb 13; 370 (7): 592–5.
  21. Kucherenko VZ, Martynchik SA, Osokina OV. Informatsionnye sredstva kontrollinga proizvodstvenno-khozyaystvennoi deyatel'nosti meditsinskoi organizatsii. Metodicheskoe posobie. Ekaterinburg: UGMA, 2008. Russian.
  22. Martynchik SA, Osokin RS, Osokina OV. Organizatsionnaya osnova monitoringa proizvodstvenno-khozyaystvennoi deyatel'nosti meditsinskoi organizatsii. In: Polesskii VA, editor. Monitorirovanie sostoyaniya zdorov'ya, kachestva i obraza zhizni naseleniya Rossii. Vliyanie povedencheskikh faktorov riska na zdorov'e naseleniya: Proceedings of the Vserossiyskaya nauchno-prakticheskaya konferentsiya; 2011 Jun 06 — 2011 Jul 06; Moscow, Russia. Moscow; 2011. p 233–5. Russian.
  23. Zerhouni EA, Alving B. Clinical and translational science awards: a framework for a national research agenda. Transl Res. 2006 Jul; 148 (1): 4–5.
  24. Academy of Medical Sciences [Internet]. A new pathway for the regulation and governance of health research, 2011. [cited 2016 Jan 13]. Available from: http://www.acmedsci.ac.uk/policy/policy-projects/.
  25. Martynchik SA. Planirovanie gosudarstvennogo (municipal'nogo zadaniya) v zdravookhranenii. Zdravookhranenie. 2012; 4: 18–23. Russian.
  26. Sully BG, Julious SA, Nicholl J. A reinvestigation of recruitment to randomised, controlled, multicenter trials: a review of trials funded by two UK funding agencies. Trials. 2013 Jun 9; 14: 166.
  27. Arnold E, Brown N, Eriksson A, Jansson T, Muscio A, Nählinder J, et al. The Role of Industrial Research Institutes in the National Innovation System. Stockholm: VINNOVA; 2007.
  28. Warlow C. A new NHS research strategy. Lancet. 2006 Jan 7; 367 (9504): 12–3.
  29. Chernova AA, Kurshakova NB. Podkhody k otsenke rezul'tativnosti sistemy menedzhmenta kachestva v nauchno-issledovatel'skikh organizatsiyakh. Innovatsionnaya ekonomika i obshchestvo. 2015; 3 (9): 90–5. Russian.
  30. Martynchik SA, Glukhova EA, Galustova LR. Trebovaniya k postroeniyu sistemy dlya otsenki rezul'tativnosti i potentsiala nauchnoi deyatel'nosti na urovne organizatsii. Sotsial'nye aspekty zdorov'ya naseleniya. 2013; 32 (4): 10. Russian.
  31. Sveiby K-E. What is Knowledge Management? [Internet]. 1996 Mar [updated 2001 Apr; cited 2016 Jan 15]. Available from: http://www.sveiby.com/articles/KnowledgeManagement.html.
  32. Kahn C, McGourty S. Performance Management at R&D Organizations. Practices and Metrics from Case Examples. Bedford, MA: The MITRE Corporation; 2009.
  33. Fadeeva IM, Osipova OYu, Fadeeva ES. Kompetentsii molodykh uchenykh dlya nauchno-issledovatel'skoi deyatel'nosti i akademicheskoi kar'ery. Integratsiya obrazovaniya. 2012; 1: 7–13. Russian.
  34. Ipatova OM, Medvedeva NV, Archakov AI, Grigor'ev AI. Translyatsionnaya meditsina — put' ot fundamental'noi biomeditsinskoi nauki v zdravookhranenie. Vestnik Rossiyskoi akademii meditsinskikh nauk. 2012; 6: 57–65. Russian.
  35. Anderson ML, Califf RM, Sugarman J; participants in the NIH Health Care Systems Research Collaboratory Cluster Randomized Trial Workshop. Ethical and regulatory issues of pragmatic cluster randomized trials in contemporary health systems. Clin Trials. 2015 Jun; 12 (3): 276–86. DOI: 10.1177/1740774515571140.
  36. Frewer LJ, Coles D, van der Lans IA, Schroeder D, Champion K, Apperley JF. Impact of the European clinical trials directive on prospective academic clinical trials associated with BMT. Bone Marrow Transplant. 2011 Mar; 46 (3): 443–7.
  37. Neaton JD, Babiker A, Bohnhorst M, Darbyshire J, Denning E, Frishman A, et al. Regulatory impediments jeopardizing the conduct of clinical trials in Europe funded by the National Institutes of Health. Clin Trials. 2010 Dec; 7 (6): 705–18.
  38. Gokhberg LM, Zaichenko SA, Kitova GA, Kuznetsova TE. Nauchnaya politika: global'nyi kontekst i rossiyskaya praktika. M.: NIU VShE; 2011. Russian.
  39. Fadeeva IM, Shamanaev PA, Sokolova MYu. Upravlenie kadrovym potentsialom issledovatel'skogo universiteta na osnove informatsionnykh sistem. Universitetskoe upravlenie: praktika i analiz. 2011; 6: 23–31. Russian.
  40. Zubova LG, Andreeva ON, Antropova OA. K voprosu o rezul'tativnosti deyatel'nosti gosudarstvennykh nauchnykh organizatsii (po otsenkam sotsiologicheskogo monitoringa 2005–2011 gg.). Innovatsii. 2012; 12 (170): 51–60. Russian.
  41. Starodubov VI, Kurakova NG, Tsvetkova LA, Markusova VA. O novykh kriteriyakh otsenki rossiiskoi akademicheskoi i vuzovskoi meditsinskoi nauki. Meditsinskoe obrazovanie i professional'noe razvitie. 2011; 1: 16. Russian.
  42. Altbach PG, Reisberg L, Yudkevich M, Androushchak G, Pacheco IF, editors. Paying the Professoriate: A Global Comparison of Compensation and Contracts. New York: Routledge, 2012.
  43. Bondarenko TV. «Rabota nad oshibkami», ili kak razrabotat' effektivnuyu sistemu KPI. Menedzhment segodnja. 2010; 4: 236–241. Russian.
  44. Martynchik SA, Glukhova EA, Galustova LR. Trebovaniya k postroeniyu sistemy dlya otsenki rezul'tativnosti i potentsiala nauchnoi deyatel'nosti na urovne organizatsii. Sotsial'nye aspekty zdorov'ya naseleniya. 2013; 32 (4): 10. Russian.